亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Protein Therapy for Acute Lung Injury

技術優勢: Direct treatment of ARDSCan utilize a number of commercially-available transport proteins such as Chariot, perpetratin, and thrombin-antithrombin (TAT) fragmentFAKp may be fused to a histidine tag which can be linked to a variety of metals including copper, nickel, and zincMay be administered through an intravenous, buccal, parenteral, or oral route, or via inhalation

詳細技術說明: ARDS is characterized by the hyperpermeability of air sacs to fluid. This technology consists of a protein, focal adhesion kinase (FAKp), which prevents the endothelial cells of the lungs from becoming hyperpermeable. When delivered intravenously by ...

*Inquiry: Peter GolikovColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*Publications: Quadri, S., and Bhattacharya, J. 2007. Resealing of Endothelial Junctions by Focal Adhesion Kinase. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L334-42. Safdar, Z., Yiming, M., Grunig, G., and Bhattacharya, J. 2005. Inhibition of Acid-induced Lung Injury by Hyperosmolar Sucrose in Rats. Am. J. Resp. and Crit. Care Med. 172: 1002-1007. Quadri, S., Bhattacharjee, M., Parthasarathi, K., Tanita, T., and Bhattacharya, J. 2003. Endothelial Barrier Strengthening by Activation of Focal Adhesion Kinase. J. Bio. Chem. 278: 13342-13349. Safdar, Z., Wang, P., Ichimura, H., Issekutz, A.C., Quadri, S., and Bhattacharya J. 2003. Hyperosmolarity enhances the lung capillary barrier. J. of Clin. Invest. 112(10): 1541-1549.

欲了解更多信息，請點擊這裡